← Leaderboards
Aaron R Sasson
Sanguine Diagnostics And Therapeutics
$729,815
Attributed
$1,739,446
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $657.7K · FY2014–19$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,739,446 · 2
By mechanism
R44$1,514,446 · 1
R41$225,000 · 1
Top collaborators
- Maneesh Jain3 shared
- Wade M Junker2 shared
- Joshua James Souchek1 shared
Most similar at Sanguine Diagnostics And Therapeutics
Same institution · by research overlap
- Wade M Junker$971,580
- Joshua James Souchek$544,416
Others in their field
Top investigators on “Early Diagnosis”
- Michael W Weiner · Northern California Institute Res &Educ$162,576,753
- Mitchell D Schnall · University Of Pennsylvania$148,421,012
- David Heimbrook · Leidos Biomedical Research, Inc.$98,656,722
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$85,695,840
- Sharon A Nachman · Johns Hopkins University$77,262,665
- Peter J O'Dwyer · University Of Pennsylvania$75,791,391
Research focus
Early DiagnosisFutureDiagnosticDistant MetastasisEvaluationFine Needle Aspiration BiopsyAdenocarcinomaDiagnosisBenignDiagnostic TestsBiological MarkersDiagnostic ImagingArchivesExcisionCell SurfaceChronic PancreatitisBaseDetectionCystCyst FluidCystic LesionCystic NeoplasmCytologyGland
Grant awards (4)
MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases$657,713
R44 · FY2019 · DK
MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases$657,713
R44 · FY2018 · DK
MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases$199,020
R44 · FY2017 · DK
Mucins in the Diagnosis and Prognosis of Pancreatic Diseases$225,000
R41 · FY2014 · CA · contact PI